Published in J Immunol on December 15, 2009
GB virus C: the good boy virus? Trends Microbiol (2012) 1.39
GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells. Antivir Ther (2010) 1.12
Semen protects CD4+ target cells from HIV infection but promotes the preferential transmission of R5 tropic HIV. J Immunol (2010) 0.97
Role of GB virus C in modulating HIV disease. Expert Rev Anti Infect Ther (2012) 0.95
Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs. Vaccine (2010) 0.90
Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication. Virology (2012) 0.90
GB virus type C infection polarizes T-cell cytokine gene expression toward a Th1 cytokine profile via NS5A protein expression. J Infect Dis (2012) 0.83
Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope prediction. J Virol (2014) 0.82
The GB virus C (GBV-C) NS3 serine protease inhibits HIV-1 replication in a CD4+ T lymphocyte cell line without decreasing HIV receptor expression. PLoS One (2012) 0.81
Transmission of GB virus type C via transfusion in a cohort of HIV-infected patients. J Infect Dis (2012) 0.81
Dengue virus serotype 1 non-structural protein NS5 expression interferes with HIV replication in a CD4+ T-cell line. Am J Trop Med Hyg (2014) 0.79
Differential clinical outcome of dengue infection among patients with and without HIV infection: a matched case-control study. Am J Trop Med Hyg (2015) 0.77
Chimpanzee GB virus C and GB virus A E2 envelope glycoproteins contain a peptide motif that inhibits human immunodeficiency virus type 1 replication in human CD4⁺ T-cells. J Gen Virol (2013) 0.76
Signal peptide-binding drug as a selective inhibitor of co-translational protein translocation. PLoS Biol (2014) 0.76
Dengue Infection in a Human Immunodeficiency Virus-1 Positive Patient Chronically Infected with Hepatitis B Virus in Western Mexico. Am J Trop Med Hyg (2016) 0.75
Virus against virus (VIVI): a potential solution against HIV/AIDS. Int Arch Med (2014) 0.75
Bayesian analysis and classification of two enzyme-linked immunosorbent assay tests without a gold standard. Stat Med (2013) 0.75
MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform (2004) 72.40
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (1985) 30.47
The role of mononuclear phagocytes in HTLV-III/LAV infection. Science (1986) 17.33
Replication of hepatitis C virus. Nat Rev Microbiol (2007) 8.31
Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science (1986) 4.79
The phylogeny of RNA-dependent RNA polymerases of positive-strand RNA viruses. J Gen Virol (1991) 4.72
Molecular biology of flaviviruses. Adv Virus Res (2003) 4.39
Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med (2004) 4.06
Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med (2001) 3.98
The NS5A protein of hepatitis C virus is a zinc metalloprotein. J Biol Chem (2004) 3.15
Hepatitis C virus NS5A: tales of a promiscuous protein. J Gen Virol (2004) 2.97
Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med (2001) 2.56
Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J Immunol (1994) 2.48
GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study. J Infect Dis (2005) 2.33
HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model. Retrovirology (2006) 2.17
G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus. Transfusion (1997) 1.96
Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.88
HIV disease progression: immune activation, microbes, and a leaky gut. Top HIV Med (2007) 1.87
Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet (2004) 1.78
GB virus type C/Hepatitis G virus. Semin Liver Dis (2003) 1.66
Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis. HIV Med (2006) 1.63
Quantification of target gene expression by imaging reporter gene expression in living animals. Nat Med (2000) 1.56
Disrupting T-cell homeostasis: how HIV-1 infection causes disease. AIDS Rev (2003) 1.49
Regulation of CC chemokine receptor 5 in hepatitis G virus infection. AIDS (2003) 1.47
GB virus C replicates in primary T and B lymphocytes. J Infect Dis (2005) 1.44
Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion. Transfusion (2006) 1.35
Role of CD4 and CD8 in T cell activation and differentiation. Adv Immunol (1993) 1.30
Full-length GB virus C (Hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J Virol (2000) 1.29
GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis (1998) 1.27
Hepatitis C virus quasispecies in patients infected with HIV-1: correlation with extrahepatic viral replication. Virology (1998) 1.27
Virus replication and cytokine production in dengue virus-infected human B lymphocytes. J Virol (2002) 1.25
An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells. Proc Natl Acad Sci U S A (2006) 1.23
Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro. J Virol (2007) 1.20
Hepatitis C virus infects T cells and affects interferon-gamma signaling in T cell lines. Virology (2006) 1.14
Taxonomy of the virus family Flaviviridae. Adv Virus Res (2003) 1.14
Enzyme-linked immunosorbent assay compared with neutralization tests for evaluation of live mumps vaccines. J Clin Microbiol (1984) 1.13
Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages. Blood (2004) 1.13
Decrease in human immunodeficiency virus type 1 load during acute dengue fever. Clin Infect Dis (2003) 1.10
GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy. AIDS (2009) 1.09
In vitro infection of human peripheral blood mononuclear cells by GB virus C/Hepatitis G virus. J Virol (1999) 1.09
Inhibition of HIV strains by GB virus C in cell culture can be mediated by CD4 and CD8 T-lymphocyte derived soluble factors. AIDS (2005) 1.06
Effect of a single ethanol exposure on HIV replication in human lymphocytes. J Investig Med (1997) 1.05
Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation. J Virol (2006) 1.04
HIV entry inhibition by the envelope 2 glycoprotein of GB virus C. AIDS (2007) 1.04
Replication or inactivation of different viruses by human lymphocyte preparations. Infect Immun (1974) 0.99
Replication of West Nile virus in equine peripheral blood mononuclear cells. Vet Immunol Immunopathol (2005) 0.98
Antibody-mediated infection of macrophages and macrophage-like cell lines with 17D-yellow fever virus. J Med Virol (1981) 0.95
Dengue virus infection of human T lymphocytes. Acta Virol (1997) 0.93
Characterization of a peptide domain within the GB virus C NS5A phosphoprotein that inhibits HIV replication. PLoS One (2008) 0.93
CD4: a co-receptor in the immune response and HIV infection. Int J Biochem Cell Biol (1997) 0.93
Myxoma virus induces extensive CD4 downregulation and dissociation of p56lck in infected rabbit CD4+ T lymphocytes. J Virol (1995) 0.93
Expression of the dengue virus type 2 NS5 protein in a CD4(+) T cell line inhibits HIV replication. J Infect Dis (2008) 0.86
GB virus type C NS5A sequence polymorphisms: association with interferon susceptibility and inhibition of PKR-mediated eIF2alpha phosphorylation. J Interferon Cytokine Res (2005) 0.85
Expression of GB virus C NS5A protein from genotypes 1, 2, 3 and 5 and a 30 aa NS5A fragment inhibit human immunodeficiency virus type 1 replication in a CD4+ T-lymphocyte cell line. J Gen Virol (2007) 0.84
South African GB virus C isolates: interactions between genotypes 1 and 5 isolates and HIV. J Infect Dis (2005) 0.84
GROWTH OF 17D YELLOW FEVER VIRUS AND FACTORS INFLUENCING ITS TRANSMISSION WITHIN CELL CULTURES IN VITRO. Acta Pathol Microbiol Scand (1964) 0.76
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology (2014) 4.15
Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med (2004) 4.06
Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron (2013) 3.27
Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med (2012) 2.77
The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med (2005) 2.50
Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol (2006) 1.98
Uterine massage to reduce blood loss after vaginal delivery: a randomized controlled trial. Obstet Gynecol (2013) 1.96
Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol (2007) 1.84
Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons. J Infect Dis (2012) 1.80
Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet (2004) 1.78
Glycosylation site-specific analysis of clade C HIV-1 envelope proteins. J Proteome Res (2009) 1.61
Epigenetic regulation of motor neuron cell death through DNA methylation. J Neurosci (2011) 1.61
Acquisition of GB virus type C and lower mortality in patients with advanced HIV disease. Clin Infect Dis (2012) 1.59
Inaccurate glycosylated hemoglobin A1C measurements in human immunodeficiency virus-positive patients with diabetes mellitus. Clin Infect Dis (2003) 1.51
The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice. Exp Neurol (2009) 1.50
Tourniquet device for hemorrhage control during cesarean section of complete placenta previa pregnancies. J Obstet Gynaecol Res (2013) 1.48
Restoration of connexin26 protein level in the cochlea completely rescues hearing in a mouse model of human connexin30-linked deafness. Proc Natl Acad Sci U S A (2007) 1.44
GB virus C replicates in primary T and B lymphocytes. J Infect Dis (2005) 1.44
Atoh1 directs the formation of sensory mosaics and induces cell proliferation in the postnatal mammalian cochlea in vivo. J Neurosci (2012) 1.43
GB virus type C interactions with HIV: the role of envelope glycoproteins. J Viral Hepat (2009) 1.41
Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model. Proc Natl Acad Sci U S A (2009) 1.40
GB virus C: the good boy virus? Trends Microbiol (2012) 1.39
A novel mechanism for connexin 26 mutation linked deafness: cell death caused by leaky gap junction hemichannels. Laryngoscope (2006) 1.36
An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging. Bioconjug Chem (2009) 1.34
Targeted connexin26 ablation arrests postnatal development of the organ of Corti. Biochem Biophys Res Commun (2009) 1.32
Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests. J Acquir Immune Defic Syndr (2002) 1.29
Impaired endothelial function in the brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Pediatr Infect Dis J (2003) 1.26
Connexin30 null and conditional connexin26 null mice display distinct pattern and time course of cellular degeneration in the cochlea. J Comp Neurol (2009) 1.25
Direct interaction with Rab11a targets the epithelial Ca2+ channels TRPV5 and TRPV6 to the plasma membrane. Mol Cell Biol (2006) 1.25
Gitelman's syndrome: towards genotype-phenotype correlations? Pediatr Nephrol (2006) 1.24
An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells. Proc Natl Acad Sci U S A (2006) 1.23
Alcohol use and HIV pharmacotherapy. AIDS Res Hum Retroviruses (2002) 1.23
Tissue involution and the acute phase response. Ann N Y Acad Sci (2003) 1.21
Diverse deafness mechanisms of connexin mutations revealed by studies using in vitro approaches and mouse models. Brain Res (2009) 1.20
Evaluation by high-resolution ultrasonography of endothelial function in brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Circ J (2002) 1.20
TBLR1 regulates the expression of nuclear hormone receptor co-repressors. BMC Cell Biol (2006) 1.14
Hyperbaric oxygen attenuates apoptosis and decreases inflammation in an ischemic wound model. J Invest Dermatol (2008) 1.14
Amnesia produced by altered release of neurotransmitters after intraamygdala injections of a protein synthesis inhibitor. Proc Natl Acad Sci U S A (2007) 1.13
GB virus type C/hepatitis G virus: a non-pathogenic flavivirus associated with prolonged survival in HIV-infected individuals. Microbes Infect (2003) 1.12
Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial. JAMA (2004) 1.11
Factors associated with seronegative chronic hepatitis C virus infection in HIV infection. Clin Infect Dis (2007) 1.09
GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy. AIDS (2009) 1.09
Digenic inheritance of non-syndromic deafness caused by mutations at the gap junction proteins Cx26 and Cx31. Hum Genet (2008) 1.08
Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles. Infect Immun (2004) 1.06
Diencephalic damage decreases hippocampal acetylcholine release during spontaneous alternation testing. Learn Mem (2003) 1.06
Real-time polymerase chain reaction microRNA detection based on enzymatic stem-loop probes ligation. Anal Chem (2009) 1.06
Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell cultures. Virology (2003) 1.05
Identification of Mycobacterium tuberculosis clinical isolates with altered phagocytosis by human macrophages due to a truncated lipoarabinomannan. J Biol Chem (2008) 1.05
Tissue kallikrein stimulates Ca(2+) reabsorption via PKC-dependent plasma membrane accumulation of TRPV5. EMBO J (2006) 1.05
The beta-glucuronidase klotho exclusively activates the epithelial Ca2+ channels TRPV5 and TRPV6. Nephrol Dial Transplant (2008) 1.05
BMI versus the metabolic syndrome in relation to cardiovascular risk in elderly Chinese individuals. Diabetes Care (2007) 1.03
Stat3 mediates expression of autotaxin in breast cancer. PLoS One (2011) 1.03
Downregulation of electroacupuncture at ST36 on TNF-alpha in rats with ulcerative colitis. World J Gastroenterol (2003) 1.02
Vertical alveolar ridge augmentation with beta-tricalcium phosphate and autologous osteoblasts in canine mandible. Biomaterials (2009) 1.01
Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8⁺ T cell function in vitro. J Leukoc Biol (2013) 1.01
GB virus C envelope protein E2 inhibits TCR-induced IL-2 production and alters IL-2-signaling pathways. J Immunol (2012) 1.00
GB virus C infection is associated with a reduced rate of reactivation of latent HIV and protection against activation-induced T-cell death. Antivir Ther (2012) 0.99
Expression of TREM-1 mRNA in acute pancreatitis. World J Gastroenterol (2004) 0.99
Connexin29 is highly expressed in cochlear Schwann cells, and it is required for the normal development and function of the auditory nerve of mice. J Neurosci (2006) 0.99
GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates. J Immunol (2010) 0.99
In vitro interaction between hepatitis C virus (HCV) envelope glycoprotein E2 and serum lipoproteins (LPs) results in enhanced cellular binding of both HCV E2 and LPs. J Infect Dis (2006) 0.98
Identification and characterization of a human monoclonal antagonistic antibody AL-57 that preferentially binds the high-affinity form of lymphocyte function-associated antigen-1. J Leukoc Biol (2006) 0.98
Recombinant hepatitis C virus-like particles expressed by baculovirus: utility in cell-binding and antibody detection assays. J Med Virol (2002) 0.97
Molecular pathology in the lungs of severe acute respiratory syndrome patients. Am J Pathol (2007) 0.96
Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis. Mol Neurobiol (2011) 0.96
Concealment of homosexual identity, social support and CD4 cell count among HIV-seropositive gay men. J Psychosom Res (2003) 0.96
Distinct gene expression profiles in peripheral blood mononuclear cells from patients infected with vaccinia virus, yellow fever 17D virus, or upper respiratory infections. Vaccine (2007) 0.96
Exchange protein directly activated by cAMP plays a critical role in bacterial invasion during fatal rickettsioses. Proc Natl Acad Sci U S A (2013) 0.95
Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis. Eur J Pharmacol (2009) 0.95
Quantitative analysis of zeptomole microRNAs based on isothermal ramification amplification. RNA (2009) 0.95
Acetylcholine release in hippocampus and striatum during testing on a rewarded spontaneous alternation task. Neurobiol Learn Mem (2005) 0.95
Early postnatal virus inoculation into the scala media achieved extensive expression of exogenous green fluorescent protein in the inner ear and preserved auditory brainstem response thresholds. J Gene Med (2013) 0.95
GB virus C particles inhibit T cell activation via envelope E2 protein-mediated inhibition of TCR signaling. J Immunol (2013) 0.94
Acetylcholine release in the hippocampus and striatum during place and response training. Learn Mem (2005) 0.94
Inactivation of Mycobacterium tuberculosis mannosyltransferase pimB reduces the cell wall lipoarabinomannan and lipomannan content and increases the rate of bacterial-induced human macrophage cell death. Glycobiology (2009) 0.94
VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humans. PLoS One (2010) 0.93
A human monoclonal antibody against insulin-like growth factor-II blocks the growth of human hepatocellular carcinoma cell lines in vitro and in vivo. Mol Cancer Ther (2010) 0.93
Characterization of a peptide domain within the GB virus C NS5A phosphoprotein that inhibits HIV replication. PLoS One (2008) 0.93
GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individuals. PLoS One (2012) 0.92